Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...
The Perrysburg gymnastics team hosted the area’s only All Around Invitational on January 20 — the Noah Ninja’s meet: ...
The FDA has granted fast-track designation to an investigational antisense oligonucleotide to treat individuals with myotonic ...
Dyne Therapeutics received fast-track designation from the Food and Drug Administration for a treatment of myotonic dystrophy type 1, a neuromuscular disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback